Methods
rteriosclerosis is a major contributor to cardiovascular disease and although there are several proposed methods of analyzing the structure and function of large arteries, most of them are complicated or need sophisticated technical equipment. Among the noninvasive and simple methods of evaluating arterial stiffness, pulse wave velocity (PWV) measurement is widely used as an index of arteriosclerosis because it is very simple, accurate, and reproducible, and thus it can be easily used for the evaluation of cardiovascular risk. Several investigations have been performed using PWV as the index of arteriosclerosis in subjects with hypertension [1] [2] [3] or end-stage renal disease [4] [5] [6] and in the elderly aged over 70 years. 7 In recent years, epidemiologic studies have been performed in Japanese-Americans living in Hawaii, 8 in well-functioning American older adults 9 and in a Danish population. 10 In our center, PWV measurements have been performed since 1987, but to the best of our knowledge, few studies have attempted to determine the relationship between PWV and cardiovascular mortality in a large group of Japanese men. The aim of this study was to determine the association between PWV and all-cause mortality and cardiovascular mortality in a large Japanese population.
(ie, diastolic BP >90 mmHg and/or systolic BP >140 mmHg), it was remeasured and these levels were reported. Hypertension was defined as a systolic BP >140 mmHg or diastolic BP >90 mmHg. Body mass index (BMI), calculated as weight (kg)/square of height (m 2 ) was used as a measure of obesity. Conventional 12-lead resting electrocardiograms (ECG) was recorded and interpreted according to the Minnesota code. ECG abnormalities were defined as being present when more than 1 of the following codes was observed: 1-1, 1-2, 4-1, 4-2, 5-1, 5-2, or 7-1. Blood samples were drawn while each subject was seated and serum levels of total cholesterol, HDL-cholesterol and triglycerides were determined enzymatically with an autoanalyzer (7150, Hitachi, Tokyo, Japan); serum glucose was determined for the 75-g OGTT: diabetes was defined as a fasting glucose level >126 mg/dl or a 2-h post load glucose tolerance test level >200 mg/dl. Glucose levels were determined by glucose oxidase method, and the assays for serum lipids were standardized using Q-PAK Chemistry Control serum 1 and 2 (Technicon Instruments Corp, Tarrytown, NY, USA).
PWV Measurement
PWV was measured using an automatic device FCP-4731 with the aid of a pulse wave input box IB-70 (Fukuda Denshi, Tokyo, Japan), according to previous studies. [11] [12] [13] One transducer was positioned over the left common carotid artery and another was placed over the left femoral artery. The device simultaneously recorded the ECG and phonocardiogram (PCG). The PWV was automatically calculated as:
where t is the time difference in foot between the carotid pulse wave and the femoral pulse wave, tc is the time interval from the beginning of the second cardiac sound on the PCG to the incisura of the carotid pulse wave (ie, the transmission time for the pulse to reach the carotid site after the opening of the aortic valve; t + tc indicates the time for the pulse wave to travel from the aortic orifice to the femoral site), D is the superficially measured linear distance from the right parasternal margin of the second intercostal space to the position of the transducer over the left femoral artery. The actual intra-arterial curvilinear distance between the aortic orifice and the femoral site was estimated to be D ×1.3. The standardization of the measured PWV for diastolic BP was performed in this study. Replicate measures of PWV in 12 subjects revealed a correlation of 0.93 between physicians.
Statistical Analysis
PWV was examined using quartiles, with the lowest quartile serving as the reference category. Quartiles were defined as follows: quartile 1 (Q1), 5.5-7.4 m/s; quartile 2 (Q2), 7.5-8.1 m/s; quartile 3 (Q3), 8.2-8.9 m/s; quartile 4 (Q4), 9.0-14.7 m/s. For proportions, we used the χ2 statistic with Bonferroni correction of the probability values, if appropriate. One-way ANOVA with Tukey's test for multiple comparisons was used to examine differences between mean values in the quartiles. The outcome events studied were cardiovascular mortality and all-cause mortality. The KaplanMeier method was used to estimate the unadjusted survival curves for the 4 PWV groups. The log-rank test was used to compare the unadjusted survival curves. Cox proportional hazards analysis was used to assess the association between PWV quartiles and study outcomes. Hazard ratios (relative risk) and 95% confidence intervals (CI) are reported. All variables related to either PWV or outcome measures were considered in the multivariate analysis. All analyses were Values are mean ± SD. SBP, systolic blood pressure; DBP, diastolic blood pressure; PP, pulse pressure; PWV, pulse wave velocity; BMI, body mass index; TC, total cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein-cholesterol; FPG, fasting plasma glucose; Smoking, current smoking habit; HT, hypertension; DM, diabetes mellitus. 
Results

Baseline Characteristics of the Participants
The characteristics of the participants are shown in Table 1 The baseline characteristics of the subjects in each PWV quartile are shown in Table 2 . BP, triglycerides and other covariates associated with arteriosclerosis significantly increased and HDL-cholesterol levels decreased as the PWV value increased.
All-Cause Mortality
Over an average follow-up of 8.2 years (32,416 personyears accrued), 499 deaths occurred, including 241 deaths from cancer and 123 from cardiovascular diseases. Mortality rates per 1,000 person-years are shown in Table 3 . The mortality rate of all causes of death for Q4 was significantly higher than that for Q1. Figure 1 shows the probabilities of overall survival according to the PWV values. The KaplanMeier time-to-event curves for death from all causes differed significantly among the 4 groups over the entire follow-up period (P<0.0001). Univariate analysis revealed that the risk ratio of all-cause mortality for Q3 was 1.50 (95%CI 1.15-1.95, P<0.01) and for Q4 it was 2.11 (95%CI 1.65-2.71, P<0.0001), using Q1 as the reference. Multivariate analysis adjusted for age, BMI, pulse pressure, fasting plasma glucose, HDL-cholesterol, triglycerides, current smoking habit and ECG abnormality showed that the risk ratio was 1.28 (95%CI 0.97-1.68, P=0.07) for the highest group (Q4) compared with the lowest (Q1) group as the reference ( Table 4) . Figure 2 shows the event-free probabilities of cardio- vascular mortality in the 4 groups. The Kaplan-Meier timeto-event curves for death from cardiovascular mortality differed significantly among them (P<0.0001). During the follow-up period, the number of cardiovascular deaths increased as the PWV level increased. The mortality rates for Q1 and Q4 were 2.19 and 6.26 per 1,000 person-years, respectively. The mortality for Q4 was 3-fold higher than that for Q1. In the Cox proportional model, univariate analysis revealed that the risk ratio of cardiovascular mortality for Q3 was 2.05 (95%CI 1.16-3.63, P<0.05) and for Q4 it was 3.06 (95%CI 1.79-5.25, P<0.0001), using the Q1 group as the reference. Using multivariate analysis, the risk ratio for Q4 was 1.83 (95%CI 1.02-3.29, P<0.05), which was adjusted for age, BMI, pulse pressure, fasting plasma glucose, HDL-cholesterol, triglycerides, current smoking habit and ECG abnormality and was significantly higher than that of the reference (Q1) ( Table 5 ).
Cardiovascular Mortality
Discussion
In the present Japanese population, a total of 499 deaths occurred during the follow-up period and 123 of these were from cardiovascular disease. PWV values were significantly associated with cardiovascular mortality in this study. Several studies have demonstrated a relationship between PWV values and the prognosis for cardiovascular diseases. The PWV value is a powerful independent predictor of mortality in subjects with hypertension, 1-3 end-stage renal failure, 4-6 diabetes 14-17 and in individuals aged over 70 years. 7 In recent years, epidemiologic investigations of PWV and prognosis have been performed in general populations. Hansen et al showed that PWV predicted a composite of cardiovascular mortality and fatal and nonfatal coronary heart disease adjusted for atherosclerotic-related factors, including 24-h ambulatory BP, in 1,678 Danish people in a general population. 10 In the Health, Aging, and Body Composition (Health ABC) study, PWV was associated with cardiovascular mortality and cardiovascular events in a community-dwelling sample of older adults. 9 Shokawa et al reported a relationship between PWV and cardiovascular mortality in Japanese-Americans living in Hawaii, where the study was followed up for 10 years. 8 To date, the present study has the largest population.
Because chronological age strongly associates with PWV 18 and mortality, we limited the age of the participants to 50-69 years. The average PWV value at baseline in this study was relatively low (8.3 m/s) compared with the study of Japanese living in Hawaii in which the mean PWV level at baseline was 9.7 m/s, even though the average age at baseline and the method of PWV measure were almost same as in the present study of Japanese living in Hiroshima. Hara et al showed that the PWV values in Japanese-Americans were higher than those in living in Japan, and they interpreted this finding as being related to differences in lifestyle and dietary habits. 19, 20 According to a pathological study comparing antemortem PWV values with postmortem aortic atherosclerosis, the PWV values significantly reflected the levels of arteriosclerosis and PWV values >9.0 m/s were thought to indicate atherosclerotic changes. 21, 22 Therefore, a PWV of 9.0 m/s is used as the standard cut-off level in clinical use for evaluation of aortic PWV. The PWV values in the Q4 group, which was the highest PWV group in the present study, were >9.0 m/s, although participants in the Q4 group tend to be slightly older than those in the other groups. Based on the present study results showing that the multivariate adjusted relative risk was significantly higher in Q4, the cut-off level of PWV 9.0 m/s in clinical use seem to be appropriate.
This evidence-based review confirms PWV as a robust and important indicator of cardiovascular disease and supports its important role in routine investigation in clinical practice.
Study Limitation
The definition of the cause of death was determined from information on death certificates, and therefore the proportion of patients with cardiovascular disease may have been underestimated. Information about heart rates, [23] [24] [25] and medication for hypertension or dyslipidemia, which are associated with arteriosclerosis, was not available in this study.
Further examination is needed to clarify the progression of cardiovascular mortality in terms of differences in lifestyles, the effects of medication 26 and gender, and to compare other new methodologies such as brachial -ankle PWV 27, 28 and CAVI (Cardio-Ankle Vascular Index). [29] [30] [31] 
Conclusion
The present study has shown that increased PWV values were significantly associated with cardiovascular disease mortality in a Japanese male population. Those patients who had PWV values >9.0 m/s had a higher risk of mortality from all causes of death, as well as cardiovascular-related death. Further epidemiologic studies and therapeutic trials are required to evaluate these findings. We believe that aortic PWV should be used as an index in daily clinical practice.
